Monitor for the company's request for a hearing and any subsequent capital raising plans; delisting would severely impact liquidity and likely trigger institutional selling given the $7M market cap.
Price Chart
Executive Summary
ENDRA Life Sciences (NDRA) received a delisting notice from Nasdaq due to failing to maintain the minimum stockholders' equity of $2.5 million, with reported equity of $2,260,120 as of December 31, 2025. The company intends to request a hearing to appeal the decision and explore options to regain compliance.
Key Facts
- Nasdaq delisting notice issued on April 20, 2026 due to failure to meet minimum stockholders' equity requirement of $2.5 million
- Company's stockholders' equity was $2,260,120 as of December 31, 2025, below Nasdaq Listing Rule 5550(b)(1)
- Company previously regained compliance in November 2025 but has now fallen below the threshold again
- Company intends to request a hearing before the Nasdaq Hearings Panel to appeal delisting
- Market cap is $7M, indicating high vulnerability to delisting impact
Financial Impact
Stockholders' equity of $2,260,120 is $239,880 below Nasdaq's $2.5 million minimum requirement
Risk Factors
- Actual delisting from Nasdaq if compliance is not regained
- Reduced liquidity and investor base if delisted
- Potential inability to raise capital on favorable terms
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-045885 |
| Document: 0001213900-26-045885-index-headers.html | 0001213900-26-045885 |
| Document: 0001213900-26-045885-index.html | 0001213900-26-045885 |
| Document: 0001213900-26-045885.txt | 0001213900-26-045885 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 425 | $4.82 | awaiting T+5 | — | $4.96 (+2.93%) |
Oct 8, 2026 19d ago | 3 | $5.46 $4.74 | ▼ −13.19% | ▼ −11.22% | $4.96 (−9.14%) |
Oct 8, 2026 19d ago | SC 13D | $5.46 $4.74 | ▼ −13.19% | ▼ −11.22% | $4.96 (−9.14%) |
Oct 1, 2026 26d ago | 425 | $6.06 $5.46 | ▼ −9.90% | ▼ −11.06% | $4.96 (−18.14%) |
Oct 1, 2026 26d ago | 8-K | $6.06 $5.46 | ▼ −9.90% | ▼ −11.06% | $4.96 (−18.14%) |
Sep 25, 2026 4w ago | 425 | $5.80 $6.31 | ▲ +8.79% | ▲ +7.59% | $4.96 (−14.47%) |
Sep 9, 2026 6w ago | 425 | $5.83 $5.13 | ▼ −12.01% | ▼ −11.67% | $4.96 (−14.91%) |
Aug 17, 2026 10w ago | 8-K | $4.51 $4.75 | ▲ +5.32% | ▲ +5.52% | $4.96 (+10.00%) |
Jul 17, 2026 14w ago | 425 | $4.99 $5.23 | ▲ +4.81% | ▲ +5.50% | $4.96 (−0.58%) |
Jul 9, 2026 15w ago | 8-K | $5.49 $5.27 | ▼ −4.01% | ▼ −3.88% | $4.96 (−9.64%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers